Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

MRKR stock hub

Marker Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MRKRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

24.3M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MRKR

In the news

Latest news · MRKR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-68.8

P25 -105.6P50 -46.5P75 -3.1

ROIC-44

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MRKR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

198

Groups with data

Currency

USD

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001094038
Company name	Marker Therapeutics, Inc.
Country	United States
Country code	US
Cusip	57055L107
Employees	5
Employees Change	-3%
Employees Change Percent	-37.5
Enterprise value	$8.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US57055L2060
Last refreshed	2026-05-10
Market cap	$24.3M
Market cap category	Nano-Cap
Price	$1.46
Price currency	USD
Rev Per Employee	709,333.8x
Sector	Healthcare
Sic	2834
Symbol	MRKR
Website	https://markertherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-49.97%
EV Sales Forward	2.97x
EV/Sales	2.33x
FCF yield	-49.35%
P/B ratio	1.45x
P/S ratio	6.86x
PS Forward	8.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-232.68%
Gross Profit	$-8.3M
Net Income	$-12.2M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-343.39%
Profit Per Employee	$-2.4M
ROA	-37.83
Roa5y	-35.24
ROCE	-74.05
ROE	-68.81
Roe5y	-79.54
ROIC	-43.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-32.72%
Cagr15y	-39.16%
Cagr1y	31.56%
Cagr20y	-40.36%
Cagr3y	0.46%
Cagr5y	-42.64%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth	-46.19x
Revenue Growth Q	-51x
Revenue Growth Years	0x
Revenue Growth3 Y	0.31x
Revenue Growth5 Y	50.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.17
Assets	$19.1M
Cash	$16.1M
Current Assets	$19.1M
Current Liabilities	$2.3M
Equity	$16.8M
Liabilities	$2.3M
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$16.1M
Net Cash By Market Cap	$66.01
Net Cash Growth	-16.28%
Net Debt Equity	$-0.96
Tangible Book Value	$16.8M
Tangible Book Value Per Share	$1.01
WACC	12.12

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.39
Net Working Capital	$728,766
Quick ratio	7.67
Working Capital	$16.8M
Working Capital Turnover	$0.2

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-70.49%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-98.1%
1Y total return	31.53%
200-day SMA	1.31
3Y total return	1.39%
50-day SMA	1.44
50-day SMA vs 200-day SMA	50over200
5Y total return	-93.79%
All Time High	6,120,061.2
All Time High Change	-100%
All Time High Date	2002-11-14
All Time Low	0.67
All Time Low Change	117.72%
All Time Low Date	2023-03-31
ATR	0.1
Beta	1.43
Beta1y	1.71
Beta2y	1.73
Ch YTD	-2.01
High	1.49
High52	4.07
High52 Date	2025-07-17
High52ch	-64.13%
Low	1.42
Low52	0.81
Low52 Date	2025-08-28
Low52ch	80.27%
Ma50ch	1.25%
Premarket Change Percent	2.08
Premarket Price	$1.47
Premarket Volume	2,420
Price vs 200-day SMA	11.11%
RSI	47.96
RSI Monthly	41.74
RSI Weekly	50.08
Sharpe ratio	0.71x
Sortino ratio	1.26
Total Return	-70.49%
Tr YTD	-2.01
Tr15y	-99.94%
Tr1m	5.04%
Tr3m	-11.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.19
Earnings Revenue Estimate	665,600x
Earnings Revenue Estimate Growth	90.66x
Operating Income	$-12.4M
Operating margin	-350.7
Price target	$10
Price Target Change	$585

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,809,746%
Float Percent	82.83%
Shares Insiders	7.42%
Shares Institutions	14.32%
Shares Out	16,673,127
Shares Qo Q	15.52%
Shares Yo Y	70.49%
Short Float	1.38%
Short Ratio	1.24
Short Shares	1.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-12.6M
Average Volume	83,208.2x
Bv Per Share	1.01
Ch10y	-98.1
Ch15y	-99.94
Ch1m	5.04
Ch1y	31.53
Ch20y	-100
Ch3m	-11.52
Ch3y	1.39
Ch5y	-93.79
Ch6m	68.81
Change	1.39%
Change From Open	0
Close	1.44
Days Gap	1.39
Dollar Volume	61,014.9
Earnings Date	2026-05-14
Earnings Time	amc
EBIT	$-12.4M
EPS	$-0.79
F Score	2
FCF	$-12M
FCF EV Yield	-145.19x
FCF Per Share	$-0.72
Financing CF	9,864,488
Fiscal Year End	December
Founded	1,999
Income Tax	$-15,156
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-18
Last Report Date	2025-12-31
Last Split Date	2023-01-27
Last Split Type	Reverse
Last10k Filing Date	2026-03-18
Ma150	1.39
Ma150ch	5.11%
Ma20	1.52
Ma20ch	-4.14%
Net CF	-2,149,593
Next Earnings Date	2026-05-22
Open	1.46
Optionable	No
Position In Range	60.61
Pre Close	1.44
Price Date	2026-05-08
Ptbv Ratio	1.45
Relative Volume	0.5x
Revenue	3,546,669x
SBC By Revenue	15.16x
Share Based Comp	537,540
Tax By Revenue	-0.43x
Tr20y	-100%
Tr6m	68.81%
Us State	Texas
Volume	41,791
Z Score	-30.28

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MRKR pay a dividend?

Capital-return profile for this ticker.

Performance

MRKR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MRKR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.3%

Float: +82.8% of shares outstanding

Insider ownership

+7.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MRKR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.0

Neutral momentum band

Price vs 200-day MA

+11.1%

50/200-day relationship not available

Beta (5Y)

1.43

More volatile than the market

Sharpe ratio

0.71

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MRKR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MRKR stock rating?

Marker Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MRKR analysis?

The full report lives at /stocks/MRKR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MRKR?

The latest report frames MRKR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MRKR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.